Prevest Denpro Complete Financial Statements

In FY2025, Prevest Denpro (PREVEST) reported revenue ₹20 Cr, net profit ₹6 Cr and EPS ₹4.62, with a net profit margin of 30.0% and ROE of 5.7%. Full financial statements from FY2023 to FY2025 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see PREVEST company profile.

3 Years of Data
2025 - 2023

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 30.00% 2025 data
EBITDA Margin 40.00% 2025 data
Operating Margin 36.00% 2025 data
Return on Assets 5.31% 2025 data
Return on Equity 5.66% 2025 data

Balance Sheet Ratios

Current Ratio 86.00 2025 data
Equity Ratio 93.81% 2025 data
Asset Turnover 0.18 2025 data

PREVEST Revenue, Net Profit & EBITDA — Year-on-Year Growth

PREVEST YoY (Sept 2024 vs Sept 2025) — revenue +17.6%, net profit +20.0%, EBITDA +14.3%, expenses +9.1%.

Revenue Growth
+17.6%
Year-over-Year
Net Profit Growth
+20.0%
Year-over-Year
EBITDA Growth
+14.3%
Year-over-Year
Expense Growth
+9.1%
Year-over-Year
Assets Growth
+18.9%
Year-over-Year
Equity Growth
+19.1%
Year-over-Year
Operating Cash Flow Growth
+25.0%
Year-over-Year
Investing Cash Flow Growth
+50.0%
Year-over-Year

PREVEST Income Statement — Revenue, EBITDA & Net Profit

Prevest Denpro revenue ₹20 Cr, EBITDA ₹8 Cr, net profit ₹6 Cr, EPS ₹4.62 (2025) — net profit margin 30.0%. Explore PREVEST true value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Jun 2023 Dec 2023
Revenue 20 20 17 20 17 17 14 16 14 14 14
Expenses 12 12 10 13 11 10 9 10 9 8 9
EBITDA 8 8 7 7 7 7 5 6 5 6 5
Operating Profit Margin % 36.00% 35.00% 34.00% 31.00% 36.00% 37.00% 34.00% 35.00% 33.00% 37.00% 33.00%
Depreciation 1 1 1 1 1 1 1 1 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 7 7 6 6 6 6 5 6 5 5 5
Tax 2 2 2 2 2 2 1 1 1 1 1
Net Profit 6 5 4 5 5 5 4 5 4 4 4
Earnings Per Share (₹) 4.62 4.28 3.67 3.93 4.01 3.98 3.06 3.77 3.04 3.40 3.03

PREVEST Balance Sheet — Assets, Liabilities & Shareholders' Equity

PREVEST total assets ₹113 Cr, total equity ₹106 Cr, total liabilities ₹ Cr (2025) — ROE 5.7%.

Years Annual Data ₹ Crores
Particulars 2025 2024
ASSETS
Total Assets 113 95
Current Assets 86 68
Fixed Assets 27 27
Capital Work in Progress 0 0
Investments 5 2
Other Assets 81 66
LIABILITIES
Total Liabilities
Current Liabilities 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 106 89
Share Capital 12 12
Reserves & Surplus 94 77

PREVEST Cash Flow Statement — Operating, Investing & Financing

Prevest Denpro operating cash flow ₹15 Cr, investing ₹-1 Cr, financing ₹-1 Cr, net cash flow ₹12 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities 15 12
Investing Activities -1 -2
Financing Activities -1 0
Net Cash Flow 12 10